Advertisement

Topics

Latest "autologous Epstein Barr virus transformed lymphoblastoid cell vaccine" News Stories

16:56 EDT 23rd October 2017 | BioPortfolio

Here are the most relevant search results for "autologous Epstein Barr virus transformed lymphoblastoid cell vaccine" found in our extensive news archives from over 250 global news sources.

More Information about autologous Epstein Barr virus transformed lymphoblastoid cell vaccine on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about autologous Epstein Barr virus transformed lymphoblastoid cell vaccine for you to read. Along with our medical data and news we also list autologous Epstein Barr virus transformed lymphoblastoid cell vaccine Clinical Trials, which are updated daily. BioPortfolio also has a large database of autologous Epstein Barr virus transformed lymphoblastoid cell vaccine Companies for you to search.

Showing "autologous Epstein Barr virus transformed lymphoblastoid cell vaccine" News Articles 1–25 of 10,000+

Extremely Relevant

Epstein-Barr Virus Increases Risk of MS

While being infected at a young age with Epstein-Barr virus generally causes few, if any, symptoms, delayed exposure into adolescence...


Our Gorilla Cousins Harbor Mono-Like Virus, Too

FRIDAY, July 14, 2017 -- Researchers say a herpes virus similar to the Epstein-Barr virus that infects people has been found in mountain gorillas. The discovery may assist in the conservation of critically endangered mountain gorillas, according to...

Coordinated repression of BIM and PUMA by Epstein–Barr virus latent genes maintains the survival of Burkitt lymphoma cells


Herpes virus in mountain gorillas has similarity to EBV found in humans

Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific Reports.

Mountain gorillas have herpes virus similar to that found in humans

Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific Reports.

Epstein-Barr Virus and Multiple Sclerosis Risk Among Different Races/Ethnicities

This U.S. study found EBV exposure to be associated with increased MS risk.

Early Detection of Nasopharyngeal Cancer With EBV DNA

Screening for Epstein-Barr virus DNA in plasma samples identified nasopharyngeal carcinoma significantly earlier compared with historical controls. Medscape Medical News

Virus that causes mono may increase risk of MS for multiple races

Like whites, Hispanic and black people who have had mononucleosis, commonly known as mono, which is caused by Epstein-Barr virus, may have an increased risk of multiple sclerosis (MS), according to a new study published in the August 30, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

Study finds virus that causes mononucleosis could raise risk of multiple sclerosis

Like whites, Hispanic and black people who have had mononucleosis, commonly known as mono, which is caused by Epstein-Barr virus, may have an increased risk of multiple sclerosis (MS), according to a new study published in the August 30, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

Epstein Barr virus, abdominal pain, and jaundice

A 22 year old man presented to the emergency department with abdominal pain, jaundice, itching, and fever. His urine was dark and stools pale.His temperature was 38.7°C and he was icteric with...

Analysis of EBV DNA in plasma samples IDs nasopharyngeal CA

(HealthDay)—Analysis of Epstein-Barr virus (EBV) DNA in plasma samples can identify early asymptomatic nasopharyngeal carcinoma, according to a study published in the Aug. 10 issue of the New England Journal of Medicine.

High fat diet linked to increased risk of relapse in kids with MS

On the other hand, high vegetable intake may halve the risk of relapse, the findings indicate. Several genetic and environmental factors, including previous infection with Epstein Barr virus, exposure to cigarette smoke, and low vitamin D levels have all been associated with a heightened risk of MS.

Chimera Virus Constructed for Potential New Lymphoma Therapy

Scientists from the Instituto de Medicina Molecular (iMM) Lisboa in Portugal say they and collaborators have created a chimera virus that allows them to study novel approaches to treat cancer caused by human herpes virus infection in a mouse model. Herpes simplex, chickenpox, cytomegalovirus, Epstein-Barr and Kaposi Sarcoma herpesvirus infect humans for life and can cause cancer in s...

Effective Strategies to Prevent Posttransplant Lymphoproliferative Disease in High-Risk Adults

Monitoring of Epstein-Barr virus viral load, but not antiviral prophylaxis, was associated with fewer cases of posttransplant lymphoproliferative disease in high-risk, adult, solid-organ transplant recipients.

Blood Test Can Screen for Rare Sinus Cancer, Study Finds

WEDNESDAY, Aug. 9, 2017 -- A new DNA blood test can catch a rare but deadly form of cancer that occurs in the sinuses, researchers report. The test, which looks for DNA evidence of Epstein-Barr virus in blood samples, was 97 percent accurate at...

New vaccine production could improve flu shot accuracy

(Duke University) For decades, vaccine manufacturers have used chicken eggs to grow the flu virus strains included in the seasonal vaccine. But because these human strains frequently mutate to adapt to their new environment, the resulting vaccine is often an imperfect match to the virus that it is supposed to protect against. Duke researchers have devised a way to keep the human influenza virus fr...

One step closer to a DNA vaccine against dengue virus

(Frontiers) In a new study, researchers inoculated mice with a new DNA vaccine candidate (pVAX1-D1ME) in order to evaluate its efficiency. They found that the vaccine candidate was able to induce persistent humoral and cellular immune responses and provided efficient protection against lethal challenge from one of the four serotypes of dengue virus (DV1). These results are encouraging for the futu...

Kite Pharma seeks European approval for Axicabtagene Ciloleucel

Kite Pharma has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for axicabtagene ciloleucel as a treatment for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), transformed follicular lymphoma (TFL), and primary mediastinal B-cell lymphoma (PMBCL) who are not eligible for autologous stem cell transplant.

Mono May Boost MS Risk (CME/CE)

(MedPage Today) -- Epstein-Barr infection tied to higher MS risk in blacks, whites, Hispanics

Cell-Based Flu Vaccine Hits Commercial Scale

Rather than rely on poultry and the eggs they produce for the manufacture of yearly flu vaccines, the World Health Organization (WHO) and FDA have encouraged vaccine manufacturers to look to other manufacturing technologies, such as use of a cell-based production model. Seqirus announced on June 21, 2017 that it has successfully used such a model for the large-scale production of the flu vaccine u...

Virus-like particle vaccine protects against RSV vaccine-enhanced respiratory disease, study finds

(Georgia State University) Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory disease that results when patients given an early form of a vaccine for respiratory syncytial virus (RSV) are exposed to RSV, according to a study led by Georgia State University.

[Personal View] Achieving safe, effective, and durable Zika virus vaccines: lessons from dengue

Newly proposed candidate Zika virus vaccines might or might not succeed in raising safe, effective, and durable protection against human Zika virus infections or syndromes. Analyses of a clinically tested and licensed dengue vaccine that failed to protect seronegative individuals from breakthrough or enhanced dengue infections suggest that poor T-cell immunity might have contributed to protection ...

Relevant

Experimental Zika virus vaccines restrict in utero virus transmission in mice

(NIH/National Institute of Allergy and Infectious Diseases) Two experimental vaccines can restrict Zika virus transmission from pregnant mice to their fetuses and can prevent Zika virus-induced placental damage and fetal demise, according to new findings published in Cell. Scientists from NIAID; Washington University School of Medicine in St. Louis; University of Texas Medical Branch (UTMB); and o...

‘Universal flu vaccine’ to be trialled this winter

Researchers are enrolling 500 participants for the trial of a flu vaccine to protect the population against all strains of the flu virus. The push to bring the vaccine to patients has been given more urgency after over-65s experienced only 30% to 40% immunity when given last year’s vaccine. read more

‘Universal flu vaccine’ to be trialed this winter

Researchers are enrolling 500 participants for the trial of a flu vaccine to protect the population against all strains of the flu virus. The push to bring the vaccine to patients has been given more urgency after over-65s experienced only 30% to 40% immunity when given last year’s vaccine. read more


Quick Search
Advertisement
 

News Quicklinks